Related Experiment Video

Updated: Mar 11, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.5K

Immunosuppression in pediatric liver transplant recipients: Unique aspects

Tamir Miloh1, Andrea Barton1, Justin Wheeler2

  • 1Texas Children's Hospital and Baylor College of Medicine, Houston, TX.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|November 23, 2016
PubMed

Insights

Optimizing immunosuppression in pediatric liver transplantation balances rejection and infection risks. Unique pediatric factors like altered pharmacokinetics and longer exposure necessitate tailored management strategies for better outcomes.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Transplant Immunology
  • Pharmacology

Background:

  • Pediatric liver transplantation outcomes have improved significantly over 50 years.
  • Optimal immunosuppression is key to balancing graft survival and infection risk.
  • Managing immunosuppression in children presents unique challenges compared to adults.

Purpose of the Study:

  • To review current immunosuppressive strategies for pediatric liver transplant recipients.
  • To highlight the specific complexities of immunosuppression management in children.
  • To identify areas for future research in pediatric transplant tolerance.

Main Methods:

  • Literature review of immunosuppressive agents and their use in pediatric liver transplantation.
  • Analysis of pharmacokinetic and pharmacodynamic differences in pediatric populations.
  • Discussion of long-term implications of immunosuppression in children.

Main Results:

  • Physiologic differences in children impact drug absorption, distribution, metabolism, and excretion.
  • Children face prolonged immunosuppression exposure, increasing risks of infection, carcinogenesis, and nonadherence.
  • Current management requires careful balancing of efficacy and toxicity.

Conclusions:

  • Pediatric liver transplant immunosuppression requires individualized approaches due to unique physiological and developmental factors.
  • Advances in tolerance and accommodation are crucial to reduce the long-term burden of immunosuppression.
  • Continued research is needed to refine immunosuppressive protocols and improve long-term quality of life for pediatric recipients.

More Related Videos

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.7K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
634
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
637
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
488
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
85.6K